OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE
Oct
04
SIF – 15° Forum Nazionale Pharma
MORE
Oct
04
2023
Oct
30
World Orphan Drug Congress 2023 – Europe
MORE
Oct
30
2023
Nov
12
ISPOR Europe 2023
MORE
Nov
12
2023

BLOG

ALL POSTS
Aug, 29 2023

MDR: EXTENSION OF TRANSITIONAL PERIOD FOR ...

With the publication in the Official Journal of the European Union, the amendment to Regulations (EU) 2017/745 and (EU) 2017/746 a...

READ
Aug, 24 2023

ENVIRONMENTAL LABELLING OF PACKAGING: REQU...

In September 2020, Legislative Decree No. 116 of 3 September 2020 was published in the Italian Official Journal (IOJ), in relation...

READ
Aug, 10 2023

ALTERNATIVE APPROACH FOR CARCINOGENICITY T...

The ICH S1B(R1) Guideline provides international regulatory guidance on approaches for evaluating the carcinogenic potential o...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY